期刊文献+

保留肋间臂神经的乳腺癌保乳术82例术后护理体会 被引量:2

下载PDF
导出
摘要 目的:探讨保留肋间臂神经的乳腺癌保乳手术的临床护理经验。方法:对82例行保留肋间臂神经的乳腺癌保乳术的患者术后实施引流管的护理,健康宣教等措施。结果:82例患者术后恢复良好,乳房外观丰满,腋窝上臂等部位无疼痛麻木感觉障碍。结论:保留肋间臂神经的乳腺癌保乳术治疗效果良好,通过术后精心护理和心里指导,能使患者接受术试,使患者顺利恢复并配合后续辅助治疗。对提高患者生活质量起到良好作用。
出处 《中国美容医学》 CAS 2012年第12X期658-659,共2页 Chinese Journal of Aesthetic Medicine
  • 相关文献

参考文献3

二级参考文献20

  • 1[1]Defriend DJ, Howell A, Nicholson RI et al. Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res, 1994, 54 (2) :408
  • 2[2]Robertson JF, Nicholson RI, Bundred NJ, et al. Comparison of the short-term biological effects of 7alpha- [9- (4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl] estra-l,3,5, (10)-triene-3, 17-beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. Cancer Res, 2001, 61 (18) :6739
  • 3[3]Wakeling AE, Dukes M, Bavler J, et al. A potent specific pure antiestrogen with clinical potential. Cancer Res, 1991, 51(15):3867
  • 4[4]Wakeling AE. Similarities and distinctions in the mode of action of different classes of antiestrogens. Endocr Relat Cancer, 2000, 7(1) :17
  • 5[5]Osborne CK, Coronado H EB, Hildenbeck SG, et al. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst,1995, 87 (10) :746
  • 6[6]Osborne CK, Jarman M, Mcague R, et al. The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth.Cancer Chemother Pharmacol, 1994, 34 (2) :89
  • 7[7]Howell A, Defriend D, Robertson J, et al. Response to a specific antiestrogen (ICI 182, 780) in tamoxifen-resistant breast cancer. Lancet, 1995, 345 (8941) :29
  • 8[8]Howell A, Defriend D, Robertson J, et al. Pharmacokinetics,Pharmacological, and antitumor effects of the specific anti-oestrogen ICI 182, 780 in women with advanced breast cancer. Br J Cancer, 1996, 74 (2) :300
  • 9[9]Mauriac L, Pippen J. E, Quaresma J, et al. Fulvestrant(FaslodexTM ) verses anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: Combined results from two multicentre trials. European Journal of Cancer, 2003, 39 (9):1228
  • 10[10]Robertson J, Osborne CK, Howell A, et al. Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: A prospective combined analysis of two multicenter trial. Cancer, 2003, 98 (2) :229

共引文献11

同被引文献21

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部